GET THE APP

..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Massimiliano Balbi

Internal Medicine Unit, Azienda Sanitaria Friuli Occidentale (AS FO), Via Savorgnano 2, San Vito al Tagliamento, PN 33078, Italy

Publications
  • Case Reports   
    COVID-19 Hepatic Prodromal Syndrome in Patient with Non-Clear Cell Metastatic Renal Cell Carcinoma: A Case Report
    Author(s): Giovanni Lo Re*, Paolo Doretto, Massimiliano Balbi and Sandro Sulfaro

    Introduction: diagnostic and therapeutic difficulties for cancer are emerging in COVID-19 pandemic. In addition to interstitial pneumonia, disseminated intravascular coagulation and sepsis, liver injury (LI) is a fairly frequent occurrence, with significant weight on evolution and prognosis of COVID-19. Its involvement is linked to cholangiocytes ACE2. Excluded other pathogenesis, LI could represent prodromal phase of COVID-19, if initial diagnostic negativity will be followed by COVID-19 positivity. Clinical case: A 59-year-old male patient has diagnosis of metastatic papillary non-clear cell renal cell carcinoma (nccRCC). After neoadjuvant Sunitinib he was submitted to right nephrectomy with caval-atrial thrombectomy in extra-corporeal circulation. Thereafter he continues Sunitinib until disease progression (PD) to bone followed by Axitini.. Read More»
    DOI: 10.37421/1948-5956.2021.13.482

    Abstract HTML PDF

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward